Cores, Á.; Michalska, P.; Pérez, J.M.; Crisman, E.; Gómez, C.; Villacampa, M.; Menéndez, J.C.; León, R.
Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease. Antioxidants 2022, 11, 112.
https://doi.org/10.3390/antiox11010112
AMA Style
Cores Á, Michalska P, Pérez JM, Crisman E, Gómez C, Villacampa M, Menéndez JC, León R.
Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease. Antioxidants. 2022; 11(1):112.
https://doi.org/10.3390/antiox11010112
Chicago/Turabian Style
Cores, Ángel, Patrycja Michalska, José Miguel Pérez, Enrique Crisman, Clara Gómez, Mercedes Villacampa, José Carlos Menéndez, and Rafael León.
2022. "Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease" Antioxidants 11, no. 1: 112.
https://doi.org/10.3390/antiox11010112
APA Style
Cores, Á., Michalska, P., Pérez, J. M., Crisman, E., Gómez, C., Villacampa, M., Menéndez, J. C., & León, R.
(2022). Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease. Antioxidants, 11(1), 112.
https://doi.org/10.3390/antiox11010112